LF
LifeTech Scientific Corporation
LFTSF · OTC
$0.20 -16.49% (-$0.04)
Market Cap ¥6.88B
P/E Ratio 30.94x
Div. Yield -
ROE 6.31%
Bulios Fair Price
$0.2
2.6% upside
Current Price
$0.2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LFTSF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
25 /100
Expensive P/B 1.97x
P/S 5.28x
P/E 30.94x
Growth
35 /100
Stable Book val. growth 11.76%
FCF growth 35.83%
EPS growth 7.29%
Profitability
65 /100
Moderate FCF margin 2.95%
Op. margin 14.29%
Gross margin 75.28%
Quality
26 /100
Poor Asset turnover 0.27x
ROA 4.54%
ROIC 3.86%
Debt
100 /100
Low Net debt/EBITDA -2.29x
Int. coverage 106.29x
Debt/Equity 0.00x
Stability
77 /100
Stable Profitable years 4
EPS volatility 19.04%
Beta 0.33x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LFTSF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Yue Hui Xie
Employees
1,245
Headquarters
Shenzhen